Grant Wheeler

Dr. Grant Wheeler

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2015 in Genome Biology
Verified
Journal Article
Open access
PDF file
RKRichard Kelwick
Richard Kelwick
IDInes Desanlis
Ines Desanlis
GWGrant Wheeler
Grant Wheeler
DEDylan R Edwards
Dylan R Edwards
The ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin motifs) enzymes are secreted, multi-domain matrix-associated zinc metalloendopeptidases that have diverse roles in tissue morphogenesis and patho-physiological remodeling, in inflammation and in vascular biology. The human family includes 19 members that can be sub-grouped on the basis of their known substrates, namely the aggrecanases or proteoglycanases (ADAMTS1, 4, 5, 8, 9, 15 and 20), the procollagen N-propeptidases (ADAMTS2, 3 and 14), the cartilage oligomeric matrix protein-cleaving enzymes (ADAMTS7 and 12), the von-Willebrand Factor proteinase (ADAMTS13) and a group of orphan enzymes (ADAMTS6, 10, 16, 17, 18 and 19). Control of the structure and function of the extracellular matrix (ECM) is a central theme of the biology of the ADAMTS, as exemplified by the actions of the procollagen-N-propeptidases in collagen fibril assembly and of the aggrecanases in the cleavage or modification of ECM proteoglycans. Defects in certain family members give rise to inherited genetic disorders, while the aberrant expression or function of others is associated with arthritis, cancer and cardiovascular disease. In particular, ADAMTS4 and 5 have emerged as therapeutic targets in arthritis. Multiple ADAMTSs from different sub-groupings exert either positive or negative effects on tumorigenesis and metastasis, with both metalloproteinase-dependent and -independent actions known to occur. The basic ADAMTS structure comprises a metalloproteinase catalytic domain and a carboxy-terminal ancillary domain, the latter determining substrate specificity and the localization of the protease and its interaction partners; ancillary domains probably also have independent biological functions. Focusing primarily on the aggrecanases and proteoglycanases, this review provides a perspective on the evolution of the ADAMTS family, their links with developmental and disease mechanisms, and key questions for the future.


1 July 2004 in Developmental Dynamics
Verified
Journal Article
Open access
PDF file
MHMichael Harrison
Michael Harrison
MAMuhammad Abu-Elmagd
Muhammad Abu-Elmagd
TGTimothy Grocott
Timothy Grocott
CYClara Yates
Clara Yates
JGJelena Gavrilovic
Jelena Gavrilovic
GWGrant Wheeler
Grant Wheeler
Matrix metalloproteinases (MMPs) are a large family of proteins in vertebrates, consisting of over 24 genes in humans, only a few of which have been identified in Xenopus. Three genes coding for MMPs in Xenopus have been identified and their expression studied during development. The membrane‐bound XMMP‐14 and ‐15 (XMT1‐MMP and XMT2‐MMP) both showed restricted expression patterns, the former principally localising to cranial neural crest tissues and the latter to the epidermis of the embryo. XMMP‐7 codes for an MMP that lacks the hemopexin‐like domain. It is expressed exclusively in macrophages or other myeloid cell types from early in development. Developmental Dynamics 231:214–220, 2004.

18 January 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
EPEudald Pascual-Carreras
Eudald Pascual-Carreras
MMMarta Marín-Barba
Marta Marín-Barba
SCSergio Castillo-Lara
Sergio Castillo-Lara
PCPablo Coronel-Córdoba
Pablo Coronel-Córdoba
MMMarta Silvia Magri
Marta Silvia Magri
TATeresa Adell
Teresa Adell
For successful regeneration, the identity of the missing tissue must be specified according to the pre-existing tissue. Planarians are ideal for the study of the mechanisms underlying this process; the same field of cells can regrow a head or a tail according to the missing body part. After amputation, the differential activation of the Wnt/β-catenin signal specifies anterior versus posterior identity. Initially, bothwnt1andnotum(Wnt inhibitor) are expressed in all wounds, but 48 hours later they are restricted to posterior or anterior facing wounds, respectively, by an unknown mechanism. Here we show that 12 hours after amputation, the chromatin accessibility of cells in the wound region changes according to the polarity of the pre-existing tissue in a Wnt/β-catenin-dependent manner. Genomic analyses suggest that homeobox transcription factors and chromatin-remodeling proteins are direct Wnt/β-catenin targets, which trigger the expression of posterior effectors. Finally, we identify FoxG as awnt1up-stream regulator, probably via binding to its first intron enhancer region.

5 August 2005 in Molecular BioSystems
Verified
Journal Article
Closed access
PDF file
MTMatthew L. Tomlinson
Matthew L. Tomlinson
RFRobert A Field
Robert A Field
GWGrant Wheeler
Grant Wheeler
Chemical genetics is a potentially powerful tool for studying developmental processes in vertebrate systems. We present data showing Xenopus laevis as a model organism in which systematic chemical genetic screens can be carried out. Previous forward chemical genetic screens, including those with developing zebrafish embryos, have demonstrated the nature and value of biological information gained with this approach. We show how amenable Xenopus is to chemical genetics by investigating a series of compounds either with known biochemical effects, or previously identified to give developmental phenotypes, on a range of biological functions, including the development of pigmentation, the heart and the central nervous system in zebrafish. We have found that the compounds give comparable phenotypes when applied to developing Xenopus embryos. We have also studied the penetrance and expressivity of these chemical genetic phenotypes in relation to genetic variation and the developmental window during which the compound is present. Finally, we assess the feasibility and the potential throughput of a screen in this vertebrate species.

17 December 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
KHKimberley Hanson
Kimberley Hanson
SRStephen D. Robinson
Stephen D. Robinson
KAKaramallah Al-Yousuf
Karamallah Al-Yousuf
AHAdam E. Hendry
Adam E. Hendry
DSDarren Sexton
Darren Sexton
GWGrant Wheeler
Grant Wheeler
The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth